Celastrus orbiculatus Extracts Inhibit Human Hepatocellular Carcinoma Growth by Targeting mTOR Signaling Pathways

Ya-Yun Qian1,2,3, Wen-Yuan Li4, Yan Yan4

  • 1Institute of Traditional Chinese Medicine and Western Medicine, School of Medicine, Yangzhou University, Yangzhou, 225009, Jiangsu Province, China. yyqian@yzu.edu.cn.

Abstract

Insights

Celastrus orbiculatus Thunb. extracts (COE) show potential as a chemotherapeutic agent for hepatocellular carcinoma (HCC). COE effectively inhibits cancer cell proliferation and tumor growth by targeting the mTOR pathway.

Area of Science:

  • Pharmacology
  • Molecular Biology
  • Oncology

Background:

  • Hepatocellular carcinoma (HCC) remains a significant global health challenge.
  • Understanding the molecular mechanisms of novel antineoplastic agents is crucial for effective cancer treatment.
  • Celastrus orbiculatus Thunb. extracts (COE) have demonstrated potential therapeutic properties.

Purpose of the Study:

  • To elucidate the molecular mechanisms behind the antineoplastic activity of Celastrus orbiculatus Thunb. extracts (COE).
  • To evaluate the efficacy of COE in inhibiting hepatocellular carcinoma cell growth and tumor progression.
  • To investigate the role of the mTOR signaling pathway in COE's anti-cancer effects.

Main Methods:

  • Construction of human hepatocellular carcinoma HepG2 cells with mammalian target of rapamycin (mTOR) knockdown (HepG2/mTOR⁻).
  • In vitro assessment of COE's effects on cell viability, apoptosis (flow cytometry, TEM), and mTOR pathway protein expression (Western blotting).
  • In vivo evaluation of COE's anti-tumor efficacy in nude mice xenograft models, with analysis of apoptosis-related protein expression via immunohistochemistry.

Main Results:

  • COE significantly inhibited HepG2/mTOR⁻ cell proliferation and induced apoptosis in a dose-dependent manner.
  • COE treatment led to the downregulation of mTOR-related signaling pathways.
  • In vivo studies demonstrated that COE significantly inhibited tumor growth in nude mice and modulated apoptosis-related proteins (Bcl-2, Bax, caspase-3).

Conclusions:

  • Celastrus orbiculatus Thunb. extracts (COE) exhibit significant antineoplastic activity against hepatocellular carcinoma.
  • COE exerts its anti-cancer effects by targeting the mTOR signaling pathway.
  • COE represents a potential chemotherapeutic drug for HCC treatment.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.7K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.3K
Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
6.5K
Hedgehog Signaling Pathway02:33

Hedgehog Signaling Pathway

The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...
9.9K
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
2.9K